Sarzi-Puttini, Piercarlo
Filippucci, Emilio
Adami, Silvano
Meroni, Pier Luigi
Batticciotto, Alberto
Idolazzi, Luca
De Lucia, Orazio
Talavera, Pablo
Kumke, Thomas
Grassi, Walter
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study
https://doi.org/10.1007/s12325-018-0751-8
Funding for this research was provided by:
UCB Pharma
Article History
Received: 10 May 2018
First Online: 24 July 2018